New Zealand Markets closed

GSK buys Tesaro for $5.1 bln

UK's GlaxoSmithKline is buying U.S. cancer specialist Tesaro for $5.1 billion in a bid to rebuild the group's pharmaceuticals business. Fred Katayama reports.